Jonathan G. Sterrett

Array ( [id] => 7743262 [patent_doc_number] => 20120021465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY' [patent_app_type] => utility [patent_app_number] => 13/246380 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27162 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021465.pdf [firstpage_image] =>[orig_patent_app_number] => 13246380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811167 [patent_doc_number] => 08133697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Methods of cleaving DNA with rationally-designed meganucleases' [patent_app_type] => utility [patent_app_number] => 13/246355 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27187 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133697.pdf [firstpage_image] =>[orig_patent_app_number] => 13246355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7755667 [patent_doc_number] => 20120028314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY' [patent_app_type] => utility [patent_app_number] => 13/246263 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27196 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028314.pdf [firstpage_image] =>[orig_patent_app_number] => 13246263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773654 [patent_doc_number] => 08119381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity' [patent_app_type] => utility [patent_app_number] => 13/245596 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27182 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119381.pdf [firstpage_image] =>[orig_patent_app_number] => 13245596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7777330 [patent_doc_number] => 20120040405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY' [patent_app_type] => utility [patent_app_number] => 13/245650 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26401 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040405.pdf [firstpage_image] =>[orig_patent_app_number] => 13245650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773600 [patent_doc_number] => 08119361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Methods of cleaving DNA with rationally-designed meganucleases' [patent_app_type] => utility [patent_app_number] => 13/245607 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26566 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119361.pdf [firstpage_image] =>[orig_patent_app_number] => 13245607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567627 [patent_doc_number] => 09290785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Method for obtaining recombinant host bacterial cells that produce hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 13/821947 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8177 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669530 [patent_doc_number] => 20110318799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'YEAST ORGANISM PRODUCING ISOBUTANOL AT A HIGH YIELD' [patent_app_type] => utility [patent_app_number] => 13/229438 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 22772 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13229438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7760384 [patent_doc_number] => 20120030783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'RATIONALLY DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY' [patent_app_type] => utility [patent_app_number] => 13/223852 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26510 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20120030783.pdf [firstpage_image] =>[orig_patent_app_number] => 13223852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807587 [patent_doc_number] => 20120058541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'ENGINEERING RESISTANCE TO ALIPHATIC ALCOHOLS' [patent_app_type] => utility [patent_app_number] => 13/214310 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31957 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058541.pdf [firstpage_image] =>[orig_patent_app_number] => 13214310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160312 [patent_doc_number] => 20120101108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Anaplastic Lymphoma Kinase In Kidney Cancer' [patent_app_type] => utility [patent_app_number] => 13/204342 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27958 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101108.pdf [firstpage_image] =>[orig_patent_app_number] => 13204342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282717 [patent_doc_number] => 08216818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Ketose 3-epimerase, its preparation and uses' [patent_app_type] => utility [patent_app_number] => 13/187718 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9797 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561224 [patent_doc_number] => 20110275057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'ALLOSTERIC CONTROL OF PROTEINS BY MANIPULATING MECHANICAL TENSION' [patent_app_type] => utility [patent_app_number] => 13/187351 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17286 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275057.pdf [firstpage_image] =>[orig_patent_app_number] => 13187351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11737418 [patent_doc_number] => 09701992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Metabolically engineered organisms for the production of added value bio-products' [patent_app_type] => utility [patent_app_number] => 13/809340 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 20464 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8351861 [patent_doc_number] => 08247190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Method for delivering cytotoxic activity to cells' [patent_app_type] => utility [patent_app_number] => 13/180359 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 7761 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039479 [patent_doc_number] => 09080178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Escherichia coli metabolic engineering oxygen independent platform strains and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/166560 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 21 [patent_no_of_words] => 28333 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11283959 [patent_doc_number] => 09499805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Methods and compositions for synthetic RNA endonucleases' [patent_app_type] => utility [patent_app_number] => 13/805240 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 32 [patent_no_of_words] => 31901 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745570 [patent_doc_number] => 20130085287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'PROCESS' [patent_app_type] => utility [patent_app_number] => 13/702706 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15094 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957721 [patent_doc_number] => 09005923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Use of Candida bombicola strains modified in their sophorolipid production' [patent_app_type] => utility [patent_app_number] => 13/701784 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 23289 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670025 [patent_doc_number] => 20110319294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'STABLE, FUNCTIONAL CHIMERIC CELLOBIOHYDROLASE CLASS I ENZYMES' [patent_app_type] => utility [patent_app_number] => 13/151190 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13151190 [rel_patent_id] =>[rel_patent_doc_number] =>)